The American College of gastroenterology emily couric lecture the adenoma-carcinoma sequence revisited: Has the era of genetic tailoring finally arrived

American Journal of Gastroenterology

Volumn 106, Issue 2, 2011, Pages 190-198

  Ahnen, Dennis J ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; BETA CATENIN; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR; NONSTEROID ANTIINFLAMMATORY AGENT;

CHROMOSOMAL INSTABILITY; COLON ADENOMA; COLON CARCINOGENESIS; COLON POLYP; COLORECTAL CANCER; DNA REPAIR; DOWN REGULATION; EPIGENETICS; GASTROENTEROLOGY; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HIGH RISK POPULATION; HUMAN; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; ONCOGENE K RAS; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE;

ADENOMA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARCINOMA; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DNA METHYLATION; DNA, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; GENETIC TESTING; HUMANS; MOLECULAR BIOLOGY; MUTATION; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS P21(RAS); SIGNAL TRANSDUCTION;

EID: 79751531115     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2010.423     Document Type: Review

References (22)

1. Jackman RJ, Mayo CW. Adenoma carcinoma sequence in cancer of the colon. Surg Gyn Obstet 1951; 93: 327-30.
2. Castleman B, Krickstein HI. Do adenomatous polyps of the colon become malignant? N Engl J Med 1962; 267: 469-75.
3. Morson BC. Precancerous lesions of the colon and rectum. Classifi cation and controversial issues. JAMA 1962; 179: 316-21.
4. Vogelstein B, Fearon ER, Hamilton SR et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319: 525-32.
5. Kinzler KW, Vogelstein B. Colorectal tumors. In: Vogelstein B, Kinzler KW (eds). The Genetic Basis of Human Cancer. McGraw-Hill: New York, 1998 pp. 565-87.
6. Siena S, Sartore-Bianchi A, Di Nicolantonio F et al. Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer. J Natl Cancer Inst 2009; 101: 1308-24.
7. Jean GW, Shah SR. Epidermal growth factor receptor monoclonal antibodies for the treatment of metastatic colorectal cancer. Pharmacotherapy 2008; 28: 742-54. (Pubitemid 351975378)
8. Jiang Y, Kimchi ET, Staveley O, Carroll KF et al. Assessment of KRAS mutation: a step toward personalized medicine for patients with colorectal cancer. Cancer 2009; 115: 3609-17.
9. Herendeen JM, Lindley C. Use of NSAIDs for the chemoprevention of colorectal cancer. Ann Pharmacother 2003; 37: 1664-74. (Pubitemid 37315109)
10. Waddell WR, Loughry RW. Sulindac for polyposis of the colon. J Surg Oncol 1983; 24: 83-7. (Pubitemid 13004158)
11. Meyskens FLJr, McLaren CE, Pelot D et al. Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial. Cancer Prev Res 2008; 1: 32-8.
12. Chan AT, Ogino S, Fuchs CS. Aspirin use and survival aft er diagnosis of colorectal cancer. JAMA 2009; 302: 649-58.
13. Rice PL, Goldberg RJ, Ray EC et al. Inhibition of extracellular signalregulated kinase 1/2 phosphorylation and induction of apoptosis by sulindac metabolites. Cancer Res 2001; 61: 1541-7. (Pubitemid 34292585)
14. Rice PL, Kelloff J, Sullivan H et al. Sulindac metabolites induce caspase- and proteasome-dependent degradation of beta-catenin protein in human colon cancer cells. Mol Cancer Ther 2003; 2: 885-92.
15. Lindor NM, Petersen GM, Hadley DW et al. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA 2006; 296: 1507-17. (Pubitemid 44465515)
16. Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology 2010; 138: 2073-87.
17. Aaltonen LA, Salovaara R, Kristo P et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 1998; 338: 1481-7. (Pubitemid 28226275)
18. Baxter NN, Goldwasser MA, Paszat LF et al. Association of colonoscopy and death from colorectal cancer. Ann Intern Med 2009; 150: 1-8.
19. Brenner H, Hoff meister M, Arndt V et al. Protection from right- and left -sided colorectal neoplasms aft er colonoscopy: population-based study. J Natl Cancer Inst 2010; 102: 89-95.
20. Lieberman D, Nadel M, Smith RA et al. Standardized colonoscopy reporting and data system: report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable. Gastrointest Endosc 2007; 65: 757-66. (Pubitemid 46629071)
21. Imperiale TF, Ransohoff DF, Itzkowitz SH, et al., Colorectal Cancer Study Group. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004; 351: 2704-14. (Pubitemid 39665324)
22. Ahlquist DA. Next-generation stool DNA testing: expanding the scope. Gastroenterology 2009; 136: 2068-73 .